<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2256">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04321265</url>
  </required_header>
  <id_info>
    <org_study_id>20-004</org_study_id>
    <nct_id>NCT04321265</nct_id>
  </id_info>
  <brief_title>Outcomes and Prognostic Factors in COVID-19</brief_title>
  <acronym>COVIP</acronym>
  <official_title>Outcomes and Prognostic Factors in Coronavirus Disease (COVID-19) in Very Old Intensive Care Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim is to study the short-term outcome of elderly ICU patients (≥ 70 years)
      suffering from COVID-19 using a multicenter and multi-national approach The secondary aim is
      to investigate the properties of a simple frailty index in this cohort, and in particular if
      this is an instrument that can be used in resource and outcome prediction in this group To
      create hypothesis for further studies, in particular on various outcome prediction

      To create hypothesis for further studies, in particular on various outcome prediction
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data are collected regarding: Pre-Admission life conditions with Frailty (CFS, optional: KATZ
      ADL); Comorbidities; ICU-Admission (e.g. SOFA), ICU-Treatment, Survival

      Data are collected electronically through an e-CRF and with baseline documentation of the
      ICU. The database is located in Denmark, at the Department of Epidemiology, University of
      Aarhus. Each ICU will only have access through the database of their own patients, and
      patient ID is not registered (Names, birth-date or social security numbers) so it is in that
      sense anonymous.

      The goal is to recruit at 200 ICUs that will give data until September. Each center aims to
      recruit 20 patients, but more patients per center are possible.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 19, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>up to 30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fragilty</measure>
    <time_frame>pre-admission</time_frame>
    <description>Fragilty will be measured by using the Clinical frailty scale (CFS) a global clinical measure of fitness and frailty in elderly people (1=very fit to 9= terminally ill)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>COVID-19</condition>
  <condition>Elderly Patients</condition>
  <condition>Critical Illness</condition>
  <condition>Survival</condition>
  <condition>Old Age</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with Infection or suspected infection with SARS-CoV-2
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 70 years

          2. ICU-Admission

          3. Infection or suspected infection with SARS-CoV-2

        Exclusion Criteria:

        1. Age &lt;70 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Christian Jung, MD</last_name>
    <phone>+2118118800</phone>
    <email>contact@vipstudy.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raphael Bruno, MD</last_name>
    <phone>+2118118800</phone>
    <email>covip@med.uni-duesseldorf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Intensive Care, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesper Fjølner, MD</last_name>
      <email>jespfjoe@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpitaux de Paris, Hôpital Saint-Antoine, service de réanimation médicale</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand Guidet, MD</last_name>
      <email>bertrand.guidet@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand Guidet, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand Guidet, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonary Disease and Vascular Medicine</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Jung, MD, PhD</last_name>
      <email>contact@vipstudy.org</email>
    </contact>
    <contact_backup>
      <last_name>Rabea Wagstaff, MA</last_name>
      <email>ctsu@med.uni-duesseldorf.de</email>
    </contact_backup>
    <investigator>
      <last_name>Christian Jung, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raphael Bruno, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Anaestesia and Intensive Care, Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Flaatten, MD PhD.</last_name>
      <email>hans.flaatten@uib.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Clinical Medecine,University of Bergen</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Flaatten, MD PhD.</last_name>
      <email>hans.flaatten@uib.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://vipstudy.org/covip-study/</url>
    <description>Related Info</description>
  </link>
  <reference>
    <citation>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.</citation>
    <PMID>32105632</PMID>
  </reference>
  <reference>
    <citation>Flaatten H, de Lange DW, Artigas A, Bin D, Moreno R, Christensen S, Joynt GM, Bagshaw SM, Sprung CL, Benoit D, Soares M, Guidet B. The status of intensive care medicine research and a future agenda for very old patients in the ICU. Intensive Care Med. 2017 Sep;43(9):1319-1328. doi: 10.1007/s00134-017-4718-z. Epub 2017 Feb 25. Review.</citation>
    <PMID>28238055</PMID>
  </reference>
  <reference>
    <citation>Flaatten H, De Lange DW, Morandi A, Andersen FH, Artigas A, Bertolini G, Boumendil A, Cecconi M, Christensen S, Faraldi L, Fjølner J, Jung C, Marsh B, Moreno R, Oeyen S, Öhman CA, Pinto BB, Soliman IW, Szczeklik W, Valentin A, Watson X, Zaferidis T, Guidet B; VIP1 study group. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years). Intensive Care Med. 2017 Dec;43(12):1820-1828. doi: 10.1007/s00134-017-4940-8. Epub 2017 Sep 21.</citation>
    <PMID>28936626</PMID>
  </reference>
  <reference>
    <citation>Rockwood K, Stadnyk K, MacKnight C, McDowell I, Hébert R, Hogan DB. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999 Jan 16;353(9148):205-6.</citation>
    <PMID>9923878</PMID>
  </reference>
  <reference>
    <citation>Guidet B, de Lange DW, Boumendil A, Leaver S, Watson X, Boulanger C, Szczeklik W, Artigas A, Morandi A, Andersen F, Zafeiridis T, Jung C, Moreno R, Walther S, Oeyen S, Schefold JC, Cecconi M, Marsh B, Joannidis M, Nalapko Y, Elhadi M, Fjølner J, Flaatten H; VIP2 study group. The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study. Intensive Care Med. 2020 Jan;46(1):57-69. doi: 10.1007/s00134-019-05853-1. Epub 2019 Nov 29.</citation>
    <PMID>31784798</PMID>
  </reference>
  <reference>
    <citation>Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970 Spring;10(1):20-30.</citation>
    <PMID>5420677</PMID>
  </reference>
  <reference>
    <citation>Jung C, Wernly B, Muessig JM, Kelm M, Boumendil A, Morandi A, Andersen FH, Artigas A, Bertolini G, Cecconi M, Christensen S, Faraldi L, Fjølner J, Lichtenauer M, Bruno RR, Marsh B, Moreno R, Oeyen S, Öhman CA, Pinto BB, Soliman IW, Szczeklik W, Valentin A, Watson X, Zafeiridis T, De Lange DW, Guidet B, Flaatten H; VIP1 study group. Electronic address: hans.flaatten@uib.no. A comparison of very old patients admitted to intensive care unit after acute versus elective surgery or intervention. J Crit Care. 2019 Aug;52:141-148. doi: 10.1016/j.jcrc.2019.04.020. Epub 2019 May 2.</citation>
    <PMID>31055187</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 19, 2020</study_first_submitted>
  <study_first_submitted_qc>March 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Principle Investigator Prof. Dr. Dr. Christian Jung</investigator_title>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Elderly patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

